Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Stoke Therapeutics, Inc. (STOK) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Stoke Therapeutics, Inc. (STOK), most recent 12 months reported: revenue $27.59M, net loss $207.9M, free cash flow -$180.68M. Latest balance sheet on file: liquid cash $292.82M. From SEC filings. Others in Pharmaceutical Preparations: Verrica Pharmaceuticals Inc. · ARCTURUS THERAPEUTICS HOLDINGS INC. · TONIX PHARMACEUTICALS HOLDING CORP. · Jaguar Health, Inc. · ABEONA THERAPEUTICS INC. · Janux Therapeutics, Inc. · PRELUDE THERAPEUTICS INC · CASI PHARMACEUTICALS, INC.

Stock screener

Watchlist